CellaVision AB
STO:CEVI
CellaVision AB
Accounts Payable
CellaVision AB
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CellaVision AB
STO:CEVI
|
Accounts Payable
kr32.2m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Accounts Payable
kr1.6B
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Accounts Payable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Getinge AB
STO:GETI B
|
Accounts Payable
kr2.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Accounts Payable
kr607m
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
Accounts Payable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CellaVision AB
Glance View
CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
See Also
What is CellaVision AB's Accounts Payable?
Accounts Payable
32.2m
SEK
Based on the financial report for Dec 31, 2024, CellaVision AB's Accounts Payable amounts to 32.2m SEK.
What is CellaVision AB's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
10%
Over the last year, the Accounts Payable growth was -1%. The average annual Accounts Payable growth rates for CellaVision AB have been -10% over the past three years , 8% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet